migraine

Combination behavioral and pharmacological interventions through telehealth platforms: Opportunities for increasing access and optimizing migraine outcomes

Telehealth Integration for Migraine Management The integration of telehealth into migraine management represents a significant advancement in the field, enabling

Combination behavioral and pharmacological interventions through telehealth platforms: Opportunities for increasing access and optimizing migraine outcomes Read Post »

Long-term safety and tolerability of zavegepant 10-mg nasal spray with concomitant use of anti-calcitonin gene-related peptide monoclonal antibodies or other select preventive migraine medications: Results from a phase 2/3 open-label study

Study Overview This phase 2/3 open-label study was designed to evaluate the long-term safety and tolerability of zavegepant, a 10-mg

Long-term safety and tolerability of zavegepant 10-mg nasal spray with concomitant use of anti-calcitonin gene-related peptide monoclonal antibodies or other select preventive migraine medications: Results from a phase 2/3 open-label study Read Post »

Scroll to Top